Outlier test for reference replicate crossover study design [Regulatives / Guidelines]

posted by abhimanyu – Banglore, 2019-08-13 15:11 (433 d 16:49 ago) – Posting: # 20494
Views: 1,647

Hello Helmut/All,

I have question regarding outlier test (Using Lund's method) for reference replicate crossover study design.

How can we find outlier? which one will be appropriate scenario for any regulatory point of view?

Scenario 1 : can we use test and individual reference (R R) to calculate standardized residual?

Scenario 2 : Can we use test and average of reference (average of R R) to calculate standardized residual?




Thanks in advance!

Abhimanyu

Complete thread:

Activity
 Admin contact
21,164 posts in 4,410 threads, 1,476 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Tuesday 08:01 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5